# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Announces Intent to Repurchase up to $500 Million of Its StockEcolab Inc. today closed on the sale of its global surgical solut...
JP Morgan analyst Jeffrey Zekauskas maintains Ecolab (NYSE:ECL) with a Neutral and raises the price target from $225 to $228.
RBC Capital analyst Ashish Sabadra reiterates Ecolab (NYSE:ECL) with a Outperform and maintains $260 price target.
Baird analyst Andrew Wittmann maintains Ecolab (NYSE:ECL) with a Neutral and raises the price target from $243 to $267.
Citigroup analyst Patrick Cunningham upgrades Ecolab (NYSE:ECL) from Neutral to Buy and lowers the price target from $267 to...
B of A Securities analyst Steve Byrne upgrades Ecolab (NYSE:ECL) from Neutral to Buy and raises the price target from $251 t...